scholarly journals S2250 High-Dose Infliximab Salvage Induces Remission in Acute Severe Ulcerative Colitis Patient With Accelerated Infliximab Clearance

2020 ◽  
Vol 115 (1) ◽  
pp. S1192-S1192
Author(s):  
Jamie Horrigan ◽  
Michael Tadros
2021 ◽  
pp. 18-19
Author(s):  
Nilima K. Shah ◽  
Ankita Patel ◽  
Umeshkumar Nakum ◽  
Ravindra Patel

Chronic inammatory demyelinating polyneuropathy (CIDP) is a rare complication of Ulcerative colitis and it is uncertain whether it is associated with Ulcerative colitis itself or with its treatment. We describe a case of CIDP-like neuropathy as an initial symptom of Ulcerative colitis. A 17 years old male patient presented with symmetrical weakness of both lower extremities with paresthesia of both hand and feet. With impression of AIDP patient was treated with plasmapheresis and discharged on tapering steroid therapy. After 3 months again presented with bilateral weakness of all four limbs associated with diarrhea and fever. Patient was diagnosed with Ulcerative colitis ,so considering previous episode as 1st episode of CIDP and with rare association with Ulcerative colitis . Patient was treated with high dose of steroids and immunosuppressive therapy. Neurological and gastrointestinal symptoms remarkably improved after treatment.


2020 ◽  
Vol 26 (5) ◽  
pp. e44-e44 ◽  
Author(s):  
Elissa Lin ◽  
Seymour Katz

Vedolizumab is a humanized monoclonal antibody that is approved for treatment of patients with moderate to severe ulcerative colitis and is thought to be both safe and effective. We present a case of vedolizumab-associated acute pancreatitis in an ulcerative colitis patient.


2011 ◽  
Vol 5 (1) ◽  
pp. 54-56 ◽  
Author(s):  
S. Rodrigues ◽  
P. Pereira ◽  
F. Magro ◽  
S. Lopes ◽  
A. Albuquerque ◽  
...  

2018 ◽  
Vol 5 (11) ◽  
pp. e781-3
Author(s):  
Nicolette J. Rodriguez ◽  
Neil Gupta ◽  
Joanna Gibson

Sign in / Sign up

Export Citation Format

Share Document